No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
CSE Bulletin: Name and Symbol Change - XPhyto Therapeutics Corp. (XPHY)
Transdermal Drug Delivery Pipeline Report 2022 - ResearchAndMarkets.com
Short Interest in XPhyto Therapeutics Corp. (OTCMKTS:XPHYF) Grows By 33.3%
XPhyto Therapeutics Corp: ON FORM 13-502F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)
XPhyto Therapeutics Corp: AB FORM 13-501F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)
XPhyto Therapeutics Corp: AUDITED ANNUAL FINANCIAL STATEMENTS - ENGLISH